Cargando…
Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes
Mild hyperthermia (HT) (40-43 °C) has been combined with temperature-sensitive liposomes (TSL), offering on-demand drug release for increased drug bioavailability and reduced systemic toxicity. Different HT regimens have been applied to trigger liposome drug release in the blood vessels (intravascul...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824668/ https://www.ncbi.nlm.nih.gov/pubmed/35145834 http://dx.doi.org/10.7150/ntno.61280 |